Sonwu Supply API Pharmaceutical Powder Regorafenib

Product Details
Customization: Available
Powder: Yes
Customized: Customized
Still deciding? Get samples of $ !
Request Sample
Diamond Member Since 2021

Suppliers with verified business licenses

Audited Supplier Audited Supplier

Audited by an independent third-party inspection agency

Importers and Exporters
The supplier has import and export rights
Years of Export Experience
The export experience of the supplier is more than 10 years
Experienced Team
The supplier has 6 foreign trading staff(s) and 2 staff(s) with over 6 years of overseas trading experience
Fast Delivery
The supplier can deliver the goods within 15 days
to see all verified strength labels (6)
  • Sonwu Supply API Pharmaceutical Powder Regorafenib
  • Sonwu Supply API Pharmaceutical Powder Regorafenib
  • Sonwu Supply API Pharmaceutical Powder Regorafenib
  • Sonwu Supply API Pharmaceutical Powder Regorafenib
  • Sonwu Supply API Pharmaceutical Powder Regorafenib
  • Sonwu Supply API Pharmaceutical Powder Regorafenib
Find Similar Products
  • Overview
  • Product Description
  • Detailed Photos
  • Function
  • Company Profile
  • Recommended products
  • FAQ
Overview

Basic Info.

Model NO.
SWP M0326
Certification
GMP, HSE, SGS
Suitable for
Adult
State
Solid
Purity
>99%
Appearance
White to Light-Yellow Powder
CAS
755037-03-7
Mf
C21h15clf4n4o3
MW
482.82
MOQ
1g/Bag
Shelf Life
2 Years
Transport Package
Vacuum Sealed Foil Bag
Specification
1g/bag
Trademark
Sonwu
Origin
China
Production Capacity
200kg/Month

Product Description

Sonwu Supply API Pharmaceutical Powder Regorafenib
Product Description
Product Name Regorafenib
Latin Name 4-(4-(3-(4-chloro-3-(trifluoromethyl)phenyl)ureido)-3-fluorophenoxy)-N-methylpicolinamide
CAS NO 755037-03-7
MF C21H15ClF4N4O3
MW 482.82
Assay 99%
Shelf life 2 Years
Form White Powder
Brand Sonwu
Place of origin China
Detailed Photos

Sonwu Supply API Pharmaceutical Powder Regorafenib

Function

1. Regorafenib targets both tumor cell proliferation and tumor vasculature through inhibition of receptors of tyrosine kinases (VEGFR, KIT, RET, FGFR, and PDGFR) and serine/threonine kinases (Raf and p38MAPK). 
2. Regorafenib prevents not only the growth of syngeneic primary 4T1 breast tumors growing orthotopically in the fat pad, but also suppresses the formation of tumor metastasis in the lung.

Company Profile

Sonwu Supply API Pharmaceutical Powder Regorafenib

Sonwu Supply API Pharmaceutical Powder Regorafenib

Sonwu Supply API Pharmaceutical Powder Regorafenib

Recommended products
 Capecitabine Everolimus Afatinib Vandetanib Gefitinib
Temozolomid Rapamycin Axitinib Sorafenib tosylate Cediranib
Cabozantinib Selumetinib Crizotinib Sunitinib malate Erlotinib
Crizotinib Lapatinib Debrafenib Cabazitaxel Ponatinib
FAQ

1. Customs clearance

1) By Express:
Normally there is no specical need for the recipient to clear the customs. If the customs has an objection,our rich experienced and peofessional group will help you clear the customs.
2) By Air and by Sea:
Our company will cooperate with the recipient to provide relevant file and information in the customs clearance procedure.
2. Payment
T/T,Western Union,MoneyGram,Trade Assurance Order,L/C etc.
 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier